Pierre Fabre acquisition
This article was originally published in The Rose Sheet
Executive Summary
French Pharmaceutical company forms Pierre Fabre Dermo Cosmetique USA subsidiary to acquire Genesis Pharmaceutical and C&M Pharmacal, marketers of Glytone and Wellskin skin care lines through dermatologists, firm announces Oct. 2. Acquisition is first step in Pierre Fabre's dermo cosmetic strategy in the U.S., company adds. Pierre Fabre will supplement Genesis' products with its own beginning with U.S. launch of Eau Thermale Avene, the company's main dermo cosmetic brand. New subsidiary will be headed by President Olivier Fontaine. Genesis President and CEO Leonard Mazur will retain his current position...